SFX by Ex Libris Inc.

Title:	Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Price, Steve yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	HAYAKAWA, M. "Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110Î± inhibitors." Bioorganic & medicinal chemistry 14.20 (2006): 6847-5844.
description	2.	Sun, D. "Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors." Bioorganic and medicinal chemistry letters 21.1 (2011): 405-410.
description	3.	Drogemuller, M. "Synthesis of cephalostatin analogues by symmetrical and non-symmetrical routes." European journal of organic chemistry 12 (1998): 2811-2831.
description	4.	Suzuki, T. "Non-hydroxamate histone deacetylase inhibitors." Current medicinal chemistry 12.24 (2005): 2867-2880.
description	5.	Bauser, M. "Discovery and optimization of 2-aryl oxazolopyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis." Bioorganic & medicinal chemistry letters 14.8 (2004): 1997-2000.
description	6.	Pretzer, D. "Stability of the experimental anticancer agent [[(4-methoxyphenyl)sulfonyl]hydrazono]acetic acid (NSC-267213). II. Effect of structural modification on stability and mechanism of degradation." International Journal of Pharmaceutics 38.1 (1987): 161-169.
description	7.	Zheng, X. "Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors." Bioorganic & medicinal chemistry 15.2 (2007): 1014-1021.
description	8.	Gauuan, Polivina a. "Superoxide dismutase mimetics: synthesis and structure-activity relationship study of MnTBAP analogues." Bioorganic & medicinal chemistry 10.9 (2002): 3013-21.
description	9.	Suzuki, T. "Rational design of non-hydroxamate histone deacetylase inhibitors." Mini reviews in medicinal chemistry 6.5 (2006): 515-526.
description	10.	Chapman, M. n. "Optimizing the pharmacology of statins: characteristics of rosuvastatin." Atherosclerosis. Supplements 2.4 (2002): 33-37.
description	11.	KNIGHT, Zachary A. "Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold." Bioorganic & medicinal chemistry 12.17 (2004): 4749-59.
description	12.	Guo, W. "Synthesis and biological assays of 9-(acylamino) homocamptothecins as DNA topoisomerase I inhibitors." Chemistry & biodiversity 10.10 (2013): 1804-15.
description	13.	Flessner, T. "N,N′-Bis(3,5-di-t-butylsalicylidene)-1,2-cyclohexanediamino-manganese(III) chloride - the Jacobsen catalyst." Journal für praktische Chemie 341.5 (1999): 436-444.
description	14.	Axten, J. "Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)." Journal of medicinal chemistry 55.16 (2012): 7193-7207.
description	15.	Reardon, David A. "Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients." Cancer chemotherapy and pharmacology 69.6 (2012): 1507-1518.
description	16.	Funabashi, K. "Enantioselective construction of quaternary stereocenter through a reissert-type reaction catalyzed by an electronically tuned bifunctional catalyst: Efficient synthesis of various biologically significant compounds." Journal of the American Chemical Society 123.43 (2001): 10784-10785.
description	17.	Martin-Kohler, A. "Furo[2,3-d]pyrimidines and oxazolo[5,4-d]pyrimidines as inhibitors of receptor tyrosine kinases (RTK)." Helvetica chimica acta 87.4 (2004): 956-975.
description	18.	Wetzel, M. "Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis." Journal of neurosurgery 103.6 (2006): 549-56.
description	19.	Mander, Lewis N. "Total Synthesis of Sordaricin." Journal of organic chemistry 70.5 (2005): 1654-1670.
description	20.	Miller, Thomas A. "Histone deacetylase inhibitors." Journal of medicinal chemistry 46.24 (2003): 5097-5116.